Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.

  title={Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment.},
  author={Viviane Hess and Roger P A'hern and Nazar Nasiri and David M King and Peter R. Blake and Desmond P. J. Barton and John H. Shepherd and Thomas Ind and Jane E Bridges and Kevin Harrington and Stanley B. Kaye and Martin Eric Gore},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  volume={22 6},
PURPOSE Invasive mucinous carcinoma of the ovary (mucinous epithelial ovarian cancer [mEOC]) is a histologic subgroup of epithelial ovarian cancer (EOC). Chemotherapy for mEOC is chosen according to guidelines established for EOC. The purpose of this study is to determine whether this is appropriate. PATIENTS AND METHODS Women with advanced mEOC (International Federation of Gynecology and Obstetrics stage III or IV) who underwent first-line platinum-based chemotherapy were compared with women… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 107 extracted citations

Mucinous ovarian cancer: A therapeutic review.

Critical reviews in oncology/hematology • 2016
View 5 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…